ANALYSIS OF A YELLOW-FEVER VIRUS ISOLATED FROM A FATAL CASE OF VACCINE-ASSOCIATED HUMAN ENCEPHALITIS

被引:104
|
作者
JENNINGS, AD
GIBSON, CA
MILLER, BR
MATHEWS, JH
MITCHELL, CJ
ROEHRIG, JT
WOOD, DJ
TAFFS, F
SIL, BK
WHITBY, SN
WHITBY, JE
MONATH, TP
MINOR, PD
SANDERS, PG
BARRETT, ADT
机构
[1] UNIV SURREY,SCH BIOL SCI,MOLEC MICROBIOL GRP,GUILDFORD GU2 5XH,SURREY,ENGLAND
[2] NATL INST BIOL STAND & CONTROLS,DIV VIROL,POTTERS BAR EN6 3QG,HERTS,ENGLAND
[3] CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,DIV VECTOR BORNE INFECT DIS,FT COLLINS,CO 80522
来源
JOURNAL OF INFECTIOUS DISEASES | 1994年 / 169卷 / 03期
基金
英国惠康基金;
关键词
D O I
10.1093/infdis/169.3.512
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The virulence of a yellow fever (YF) virus (P-16065) isolated from a fatal case of vaccine-associated viral encephalitis was investigated. P-16065 appeared identical to its parent vaccine virus (17D-204 USA, lot 6145) when examined with monoclonal antibodies except that YF wild type-specific MAb S24 recognized P-16065 but not 17D-204 USA 6145. Thus, a mutation of at least one epitope on the envelope (E) protein had occurred. Unlike 17D-204 USA 6145 and other 17D vaccine viruses, P-16065 was neuroinvasive and virulent for mice after intranasal inoculation, and neurovirulent for monkeys after intracerebral inoculation. The E protein of P-16065 differed from 17D-204 USA by two amino acids at positions 155 and 303. Changes at amino acid position 155 are found in other YF vaccine viruses that are not neurovirulent, and it is therefore postulated that the change at position 303 is involved in the alteration of the phenotype of P-16065 and may be important for virulence of YF virus.
引用
收藏
页码:512 / 518
页数:7
相关论文
共 50 条
  • [21] A Case Suspected for Yellow Fever Vaccine-Associated Viscerotropic Disease in the Netherlands
    van de Pol, Eva M.
    Gisolf, Elizabeth H.
    Richter, Clemens
    JOURNAL OF TRAVEL MEDICINE, 2014, 21 (06) : 421 - 424
  • [23] YELLOW-FEVER - REPORT OF A FATAL CASE IN THE PARIS AREA
    BELAICHE, J
    BENDERSKY, N
    CARLET, J
    VESIN, P
    LANGE, F
    LAFAIX, C
    RAPIN, M
    CATTAN, D
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1980, 4 (11): : 799 - 803
  • [26] YELLOW-FEVER VACCINE AND AVIAN-LEUKOSIS VIRUS
    NOTTEBART, HC
    ANNALS OF INTERNAL MEDICINE, 1984, 101 (01) : 148 - 148
  • [27] YELLOW FEVER VACCINE VIRUS AND IGM ANTIBODY DETECTION IN URINE AND CEREBROSPINAL FLUID IN PATIENTS WITH YELLOW FEVER VACCINE-ASSOCIATED VISCEROTROPIC DISEASE
    Garcia, Maria
    Mannani, Enrique
    Bolarte, Jose
    Pachas, Paul
    Figueroa, Dana
    Merino, Nancy
    Gutierrez, Victoria
    Miraval, Maria
    Espinoza, Manuel
    Matos, Eduardo
    Cabezas, Cesar
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 269 - 269
  • [28] MOLECULAR ANALYSIS OF YELLOW-FEVER VIRUS 17DD VACCINE STRAIN
    POST, PR
    SANTOS, CND
    CARVALHO, R
    LOPES, OS
    GALLER, R
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1991, 86 (02): : 239 - 246
  • [29] Severe Yellow fever vaccine-associated disease: a case report and current overview
    Slesak, Guenther
    Gabriel, Martin
    Domingo, Cristina
    Schaefer, Johannes
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (16) : 1219 - 1222
  • [30] Yellow fever vaccine-associated neurotropic disease (YEL-AND) - A case report
    Florczak-Wyspianska, Jolanta
    Nawotczynska, Ewa
    Kozubski, Wojciech
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2017, 51 (01) : 101 - 105